Literature DB >> 20633382

State of the art: Pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation.

Walter Paulus1, Joseph Classen, Leonardo G Cohen, Charles H Large, Vincenzo Di Lazzaro, Michael Nitsche, Alvaro Pascual-Leone, F Rosenow, John C Rothwell, Ulf Ziemann.   

Abstract

The combination of brain stimulation techniques like transcranial magnetic stimulation (TMS) with CNS active drugs in humans now offers a unique opportunity to explore the physiologic effects of these substances in vivo in the human brain. Motor threshold, motor evoked potential size, motor evoked potential intensity curves, cortical silent period, short-interval intracortical inhibition, intracortical facilitation, short-interval intracortical facilitation, long-interval intracortical inhibition and short latency afferent inhibition represent the repertoire for investigating drug effects on motor cortical excitability by TMS. Here we present an updated overview on the pharmacophysiologic mechanisms with special emphasis on methodologic pitfalls and possible future developments or requirements.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20633382     DOI: 10.1016/j.brs.2008.06.002

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  112 in total

Review 1.  Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.

Authors:  Natasha Radhu; Lakshmi N Ravindran; Andrea J Levinson; Zafiris J Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

2.  Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder.

Authors:  Margaret A Richter; Danilo R de Jesus; Sylco Hoppenbrouwers; Melissa Daigle; Jasna Deluce; Lakshmi N Ravindran; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

Review 3.  Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future.

Authors:  Catarina Freitas; Helena Mondragón-Llorca; Alvaro Pascual-Leone
Journal:  Exp Gerontol       Date:  2011-04-14       Impact factor: 4.032

Review 4.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

5.  Boosting brain excitability by transcranial high frequency stimulation in the ripple range.

Authors:  Vera Moliadze; Andrea Antal; Walter Paulus
Journal:  J Physiol       Date:  2010-12-15       Impact factor: 5.182

Review 6.  Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices.

Authors:  Angel V Peterchev; Timothy A Wagner; Pedro C Miranda; Michael A Nitsche; Walter Paulus; Sarah H Lisanby; Alvaro Pascual-Leone; Marom Bikson
Journal:  Brain Stimul       Date:  2011-11-01       Impact factor: 8.955

7.  Cortical excitability changes over time in progressive multiple sclerosis.

Authors:  Samar S Ayache; Alain Créange; Wassim H Farhat; Hela G Zouari; Catherine Lesage; Ulrich Palm; Mohammed Abdellaoui; Jean-Pascal Lefaucheur
Journal:  Funct Neurol       Date:  2015 Oct-Dec

8.  Randomized Sham Controlled Double-blind Trial of Repetitive Transcranial Magnetic Stimulation for Adults With Severe Tourette Syndrome.

Authors:  Angeli Landeros-Weisenberger; Antonio Mantovani; Maria G Motlagh; Pedro Gomes de Alvarenga; Liliya Katsovich; James F Leckman; Sarah H Lisanby
Journal:  Brain Stimul       Date:  2014-12-03       Impact factor: 8.955

9.  Modulation of motorcortical excitability by methylphenidate in adult voluntary test persons performing a go/nogo task.

Authors:  Johannes Buchmann; A Dueck; W Gierow; H Zamorski; S Heinicke; H Heinrich; J Hoeppner; T Klauer; O Reis; F Haessler
Journal:  J Neural Transm (Vienna)       Date:  2009-12-10       Impact factor: 3.575

10.  The neurophysiological effects of single-dose theophylline in patients with chronic stroke: A double-blind, placebo-controlled, randomized cross-over study.

Authors:  Heidi M Schambra; Isis E Martinez-Hernandez; Kevin J Slane; Amelia K Boehme; Randolph S Marshall; Ronald M Lazar
Journal:  Restor Neurol Neurosci       Date:  2016-09-21       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.